SAN DIEGO, CA–(Business Wire – Sept 23, 2011) – Medical Marijuana Inc (OTC: MJNA) is pleased to announce that studies have shown Cannabidiol (CBD) has anti-inflammatory properties. Medical Marijuana Inc. through CannaBANK has a patent pending on an extraction method from Cannabis (Marijuana) and its industrialized non psychoactive counterpart Hemp, allowing Cannabidiol (CBD) to be isolated in its pure form. Once isolated the Cannabidiol can be added as a direct counter agent or as an additive to other current anti-inflammatory products.
Medical Marijuana Inc. is planning on expanding its Cannabidiol sales through licensing agreements with companies already involved in the heavily marketed nutraceutical and pharmaceutical markets.
Resources and Abstracts on Anti-inflammatory properties of Cannabidiol :
United States National Library of Medicine (PubMed)
http://www.ncbi.nlm.nih.gov/pubmed/19199042
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034694/
http://www.ncbi.nlm.nih.gov/pubmed/19070683
http://www.ncbi.nlm.nih.gov/pubmed/18641283
http://www.ncbi.nlm.nih.gov/pubmed/18469842
http://www.ncbi.nlm.nih.gov/pubmed/14963641
ABOUT MEDICAL MARIJUANA INC (OTC: MJNA)
Our mission is to be the world’s premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate, invest in and purchase value-added sustainable companies, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, pay homage to the visionaries and activists of the past and present, and provide the platform from which the industry can emerge into a global sustainable economy for all. Medical Marijuana Inc recognizes the vast and unequaled opportunities that exist in the rapidly expanding hemp and medical marijuana industries. The scientific recognition of cannabis has brought legalized marijuana use to the forefront of mainstream discussion, thus opening the door for safe and lucrative investment opportunities.
www.medicalmarijuanainc.com
http://www.facebook.com/mjnainc
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana Inc to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the Food and Drug Administration (FDA), products and statements are not intended to diagnose, treat, cure, or prevent any disease.
Contact Information:
Medical Marijuana Inc.
2665 Ariane Drive Suite 207
San Diego, CA 92117
888-OTC-MJNA (888-682-6562)
